Reporting owner · Q3 2026 · CIK 1702969

Stout Jay S: insider trades.

Stout Jay S reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($248K), across 1 company.

Transactions
5
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Stout Jay S

Companies

CompanyRelationshipTransactions
Immunovant, Inc. (IMVT)Officer · Chief Technology Officer5

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-07-23Immunovant, Inc.S2,857$38.69205,341Form 4
2026-07-08Immunovant, Inc.S1,399$39.53208,275Form 4
2026-07-08Immunovant, Inc.S77$39.99208,198Form 4
2026-07-08Immunovant, Inc.S105$39.99209,674Form 4
2026-07-08Immunovant, Inc.S1,906$39.53209,779Form 4

Questions

What stock did Stout Jay S buy or sell?

Stout Jay S reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($248K), across 1 company.

Is Stout Jay S the same person as other filers with this name?

This page covers SEC CIK 1702969 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/stout-jay-s-1702969.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.